GV
Portfolio companies
GV is on record against 57 companies.
Abacus
About.me
Acalvio
Accent Therapeutics
Adagio Therapeutics
Adapter
Adelphic Mobile
Aera Therapeutics
Affinia Therapeutics
Again
Agtonomy
Ahana
Air Protein
Airtime
Alector
Aledade
Alethea
Alkira
Allara Health
Altana AI
AltspaceVR
Ambition
AMP Robotics
Anchor
Andela
AngelList
Ankyra Therapeutics
Anomali
Antiva Biosciences
Apptentive
Apptimize
Appurify
Apteligent
Arcus Biosciences
Arda Therapeutics
Areteia Therapeutics
Armadin
ARMO BioSciences
Arrakis
Arsanis
Artifact
Aspen Neuroscience
Aspire Health
Astrid
Attio
Autolus
Dandelion Energy
Dapper Labs
Dasient
DataFox
Datanyze
Daydream
dbt Labs
Decibel Therapeutics
Deepset
Delighted
Delphia Therapeutics
Geography
Mountain View, North America
Investment focus
GV invests across all stages, from seed to growth, targeting life sciences, healthcare, AI, enterprise, and climate sectors. The firm is geographically focused on the United States, with primary operations in Mountain View, California.
Related investors
- Google VenturesAlso backs Artifact and Autolus and 55 more of the same companies
- M.G. SieglerAlso backs Artifact and Ambition and 4 more of the same companies
- Promus VenturesAlso backs Ambition and AngelList and 1 more of the same companies
- Paladin Capital GroupAlso backs Anomali and Acalvio
- Amadeus Capital PartnersAlso backs Altana AI
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.